Ligand validation:3GGG

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 3GGG designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3GGG_NAD_A_3686	92%	15%	0.086	0.977	2.02	1.72	7	9	0	0	100%	1
3GGG_NAD_B_4686	89%	15%	0.103	0.982	1.66	2.12	6	10	0	0	100%	1
3GGG_NAD_C_5686	88%	14%	0.101	0.977	1.78	2.08	8	17	2	0	100%	1
3GGG_NAD_D_6686	84%	11%	0.096	0.959	1.96	2.18	9	10	2	0	100%	1
3GGP_NAD_B_312	95%	19%	0.074	0.978	1.86	1.59	7	9	1	0	100%	1
2G5C_NAD_D_6686	83%	19%	0.082	0.941	1.84	1.6	5	5	1	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	10%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.